Venrock Adviser, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001615982

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 33 positions · Total reported value $3.30B · Top-10 concentration 80.4% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 35.1% · 4 new · 5 cut · 4 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.9% · vs SPY +10.0% · Prev Value $2.68B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Venrock Adviser, LLC disclosed 33 equity positions with a combined reported value of $3.30B. The filing implies a focused portfolio: its ten largest positions account for 80.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were APGE ($1.13B), ORKA ($394.81M), ERAS ($327.78M). By sector, the heaviest allocations are Health Care 65.7%, Financials 0.1%. Versus the prior quarter, allocation shifted toward Other (+2.6pp) and away from Health Care (-2.7pp).

Versus the prior quarter, Venrock Adviser, LLC opened 4 new positions, trimmed 5 and fully exited 4, a turnover rate of 35.1% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q2 2026 were ACHV ($17.96M), PBLS ($17.11M), RACC ($3.21M).

Of the 4 positions fully exited versus the prior quarter, the largest were KALV ($130.33M), ENGN ($32.49M), TENX ($26.79M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ACHV ACHIEVE LIFE SCIENCE INC · $17.96M
  • PBLS PARABILIS MEDICINES INC COM · $17.11M
  • RACC RESEARCH ALLIANCE CORP III · $3.21M
  • INM InMed Pharmaceuticals Inc · $50.66K

Fully Exited (vs previous quarter)

  • KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $130.33M
  • ENGN ENGENE THERAPEUTICS INC · prev qtr: $32.49M
  • TENX TENAX THERAPEUTICS INC · prev qtr: $26.79M
  • SEPN SEPTERNA INC · prev qtr: $12.16M

Insider Transactions (Form 4)

Latest Venrock Adviser, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Venrock Adviser, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 33 US equity positions with a combined value of $3.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79382 (status: Approved), registered 2014-04-09
  • Regulatory AUM (Form ADV): $4.50B as of 2026-04-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 33 positions · $3.30B reported value (Q2 2026)
  • Top 10 holdings = 80.4% of reported value
  • Largest position: APGE (APOGEE THERAPEUTICS INC) at 34.2%
  • Average position size: $99.94M

Sector Tilt

  • Health Care 65.7%
  • Financials 0.1%
  • (classified holdings cover 66% of value)

Quarterly Activity

  • Q2 2026: 4 new, 5 added, 5 reduced, 4 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 65.7%
Financials 0.1%
Other 34.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.49M $1.13B 34.18%
34.18%
Hold
2 4.15M $394.81M 11.97%
11.97%
Hold
3 17.89M $327.78M 9.94%
9.94%
Add
4 2.99M $265.05M 8.04%
8.04%
Reduce
5 1.18M $115.03M 3.49%
3.49%
Hold
6 10.35M $101.61M 3.08%
3.08%
Hold
7 3.60M $93.73M 2.84%
2.84%
Hold
8 14.75M $90.84M 2.75%
2.75%
Add
9 3.22M $71.56M 2.17%
2.17%
Hold
10 1.64M $63.55M 1.93%
1.93%
Reduce
11 3.26M $59.85M 1.81%
1.81%
Reduce
12 3.04M $56.00M 1.70%
1.70%
Hold
13 2.17M $48.28M 1.46%
1.46%
Hold
14 1.60M $47.80M 1.45%
1.45%
Hold
15 6.84M $47.36M 1.44%
1.44%
Add
16 4.32M $46.78M 1.42%
1.42%
Hold
17 2.13M $38.40M 1.16%
1.16%
Hold
18 6.43M $37.97M 1.15%
1.15%
Hold
19 3.21M $36.95M 1.12%
1.12%
Hold
20 526.33K $26.71M 0.81%
0.81%
Reduce
21 3.85M $25.46M 0.77%
0.77%
Hold
22 1.38M $25.13M 0.76%
0.76%
Hold
23 8.70M $21.30M 0.65%
0.65%
Hold
24 2.04M $19.82M 0.60%
0.60%
Add
25 4.98M $18.68M 0.57%
0.57%
Reduce
26 2.75M $17.96M 0.55%
0.55%
New
27 625.00K $17.11M 0.52%
0.52%
New
28 632.93K $16.42M 0.50%
0.50%
Hold
29 1.01M $13.31M 0.40%
0.40%
Hold
30 500.00K $13.20M 0.40%
0.40%
Hold
31 1.93M $9.03M 0.27%
0.27%
Add
32 300.00K $3.21M 0.10%
0.10%
New
33 32.69K $50.66K 0.00%
0.00%
New

FAQ

What did Venrock Adviser, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Venrock Adviser, LLC reported 33 equity positions worth $3.30B in aggregate; its largest disclosed positions were APGE ($1.13B), ORKA ($394.81M), ERAS ($327.78M).

How large is Venrock Adviser, LLC's portfolio?

Venrock Adviser, LLC reported $3.30B of long equity holdings across 33 positions as of 2026-Q2. Top-10 holdings account for 80.4% of reported value.

What is Venrock Adviser, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/venrock-adviser/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →